Transmembrane pH-Gradient Polymersomes for Ammonia Sequestration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hyperammonemia and trimethylaminuria, such as non-absorbable disaccharides and antibiotics, are ineffective in controlling symptoms and are associated with adverse reactions, and existing ammonia removal methods like hemodialysis are invasive and unsuitable for chronic conditions.
Innovation Solution
Development of transmembrane pH-gradient polymersomes composed of non-biodegradable amphiphilic block-copolymers, specifically poly(styrene)-b-poly(ethylene oxide), which create a pH gradient to selectively sequester ammonia and its methylated analogs in the gastrointestinal tract and on the skin, providing a stable and effective detoxification mechanism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If non-absorbable disaccharides and antibiotics are used to treat hyperammonemia, then ammonia removal is achieved, but adverse reactions occur and symptoms are not effectively controlled
Solution Approach 1:
The patent changes the chemical parameter of the treatment agent by using polymers with specific functional groups (carboxyl, hydroxyl, amino) that selectively interact with ammonia through acid-base chemistry, rather than using non-specific adsorbents or antibiotics. This selective chemical interaction achieves effective ammonia removal without the adverse reactions associated with conventional treatments.
Solution Approach 2:
The polymer acts as an intermediary substance between ammonia and the body's metabolic processes. The polymersome membrane serves as a selective barrier that allows ammonia to be captured and retained within the vesicle structure, preventing its harmful effects while maintaining bodily functions. This intermediary mechanism avoids direct toxic effects on the body.
2Reliability
If hemodialysis is used to remove ammonia, then effective ammonia removal is achieved, but the procedure is invasive and unsuitable for chronic conditions
Solution Approach 1:
The polymer-based system provides self-service ammonia removal through passive diffusion and ion trapping mechanisms. The polymersomes automatically capture ammonia from the gastrointestinal tract or blood without requiring external mechanical intervention, electrical currents, or invasive procedures. This passive, self-regulating mechanism makes it suitable for chronic use unlike hemodialysis.
Solution Approach 2:
The patent replaces the mechanical system of hemodialysis (requiring physical access to blood vessels, membranes, and monitoring equipment) with a chemical-biological system using polymers that selectively bind ammonia through chemical interactions. This substitution eliminates the need for invasive mechanical procedures while maintaining effective ammonia removal.
3Quantity of substance
If carbon adsorbents are used to sequester ammonia, then ammonia binding is achieved, but binding capacity is insufficient and interference with endogenous substances occurs
Solution Approach 1:
The patent applies local quality by designing polymers with specific functional groups (carboxyl, hydroxyl, amino) located at particular positions within the polymer structure. These localized functional groups provide selective affinity for ammonia while the rest of the polymer structure maintains compatibility with endogenous substances. This localized functional differentiation enables high ammonia binding capacity without interfering with normal bodily functions.
Solution Approach 2:
The invention uses composite polymer structures combining multiple functional groups and polymer chains to create a material with enhanced ammonia binding capacity. The composite nature of the polymers (with different functional groups working synergistically) allows simultaneous high capacity ammonia sequestration and selectivity, avoiding interference with endogenous substances that single-component adsorbents cannot achieve.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymersomes effectively capture ammonia and trimethylamine in simulated gastrointestinal fluids and topical formulations, maintaining stability and efficacy in harsh environments, offering a potent and selective treatment for hyperammonemia and trimethylaminuria without adverse reactions.
Implementation Method 1
transmembrane pH-gradient polymersomes
Implementation Method 2
create a pH gradient to selectively sequester ammonia and its methylated analogs
Implementation Method 3
polymersomes composed of non-biodegradable amphiphilic block-copolymers
Implementation Method 4
amphiphilic block-copolymers, specifically poly(styrene)-b-poly(ethylene oxide)
Data Source
AI summary
The present invention provides polymersomes comprising non-biodegradable amphiphilic block-copolymers and their enteral (e.g., oral) or topical use in the treatment of an ammonia or ammonia methylated analog-associated disease or disorder or symptom thereof (e.g., hyperammonemia or trimethylaminuria). More particularly, it provides a polymersome comprising (a) a membrane, which comprises a block copolymer of poly(styrene) (PS) and poly(ethylene oxide) (PEO), wherein the PS/PEO molecular weight ratio is higher than 1.0 and lower than 4.0; and (b) a core which encloses an acid. It also provides a method of making the polymersome comprising mixing the copolymer-containing organic solvent phase with an aqueous phase containing the acid.